5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N
| Product Name |
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N
|
| Product Code |
DA-A068-22
|
| Chemical name |
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N
|
| Synonyms |
5-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-imidazole-4,5-13C2-3-15N-4-carboxamide; 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-13C2,15N; AICAR-13C2,15N; Acadesine-13C2,15N; 5-Amino-4-imidazolecarboxamide Riboside-13C2,15N; Arasine-13C2,15N;
|
| Impurity |
NA
|
| CAS Number |
1609374-70-0
|
| Alternate CAS # |
NA
|
| Molecular form |
C713C2H14N315NO5
|
| Appearance |
White Solid
|
| Melting Point |
NA
|
| Mol. Weight |
261.21
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
stable isotopes,impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals
|
| Boiling Point |
NA
|
| Applications |
A labelled nucleoside analogue that is able to enter nucleoside pools and is able to significantly increase levels of adenosine during periods of ATP breakdown. Adenosine-regulating agents (ARAs) have been recognized for therapeutic potential in myocardial ischemia. Cardioprotective.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
